The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
about
Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogensCell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epitheliumAntimicrobial proteins and polypeptides in pulmonary innate defenceHuman alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequencesVitamin D and the anti-viral stateVitamin D and molecular actions on the immune system: modulation of innate and autoimmunityThe vitamin D-antimicrobial peptide pathway and its role in protection against infectionAntimicrobial peptides and the skin immune defense systemRoles of antimicrobial peptides such as defensins in innate and adaptive immunityPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesThe Innate Immune System in Acute and Chronic WoundsCathelicidin impact on inflammatory cellsNovel adjunctive therapies for the treatment of tuberculosisγδ-T cells: an unpolished sword in human anti-infection immunityCholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and diseaseThe new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasisAnti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIVAntimicrobial peptides: their role as infection-selective tracers for molecular imagingStructural and Functional Analysis of the Pro-Domain of Human Cathelicidin, LL-37Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasisThe Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.MALDI MS imaging as a powerful tool for investigating synovial tissue.The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells.The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthHuman antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.Differential activity of innate defense antimicrobial peptides against Nocardia species.Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progressionA potential wound-healing-promoting peptide from salamander skin.NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharideCirculating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro.Paneth cell α-defensins in enteric innate immunityStaphylococcus colonization of the skin and antimicrobial peptides.Peptide-based Antifungal Therapies against Emerging Infections.
P2860
Q24336171-203B2DC8-69E1-4D8E-83FC-46CAA4E2B674Q24537181-D468AB74-A768-40DE-8B2E-0151C994C50AQ24541575-5425E1D4-A890-4333-85E7-DF3337445A4AQ24555744-C3CA11D1-9DC9-496A-B296-28EC6EB0CF81Q24613615-26245D68-FB14-4BB6-B627-48FACB44931DQ24630997-B4CE05CF-29C8-4BE1-A909-EB34945E7DA2Q24647840-B703D666-5F5B-46BB-BCBB-E1DB43FF9E32Q24654981-DFABE6D7-E944-40F5-9765-32B677E68CECQ24675023-CCCA0750-DBDD-46FE-9F4E-32AA6732EFDAQ26765450-2909F34F-7DA0-4CBF-B072-3F468EC9906FQ26767062-5A7EDF4A-2877-4A7D-8377-E7E9B99B0C5CQ26777983-CD46668A-9DF7-420F-97A0-A5F8E759EBD3Q26829957-7076EF02-95B3-4812-913C-FAF06E5CA25EQ26994963-6CC65F9D-4675-4246-8BEE-4885D01CD3D6Q26998399-659A7C7A-3B91-4C1E-A931-764CCDF70662Q27007680-6EE830E9-B8D3-4F17-8B71-21EE9116CCCFQ27011921-83E3C689-864F-4352-8609-E17CE1A92766Q27014021-26E485C9-85F2-4C84-ABC5-F16ACBCDB175Q27676356-3F6586CA-691E-4BD3-9074-BD98940626ABQ28484943-75AF9154-A21B-47AB-BC02-B9D003AB6095Q28548287-4CFC5C16-5578-4A65-A3FF-58129845EB5DQ30151971-C0A9ABD3-FF3B-48F1-80BB-70AD26915CF9Q30179435-31F1E6F9-6A01-4A7E-AB52-2848B78B0158Q30460140-0867647A-51EA-49E5-B8FC-66D65C1F23FCQ30486489-4C819D12-D4DF-4F75-B17E-0E717298AB8BQ30490685-57F90EEF-E26E-4B1E-9880-945C3992632FQ30543181-E8BA041F-09E0-4EBC-943A-593ED03AB1CFQ30933550-306594EA-7C98-465B-AD3B-AECB915DD44DQ33267198-B18ADB87-57F7-489E-9389-30C8382ED11EQ33336048-0B85035E-9AD7-4A66-937A-6A362B56542BQ33533652-A10801CA-B659-4CC6-BA0C-D8B51DBADE7DQ33535953-A4C0FD09-2C60-45D1-895A-58345A364DDEQ33576200-A110D938-3955-4283-BF78-058DE44A3745Q33621811-38D36BDC-3F29-4582-9136-B4EDA8B9F4B6Q33667766-27BD0DF7-CE86-4ED0-A680-6E2832657BDBQ33749859-07E9B3F0-1E60-4C4B-A57A-C5FBA5BA047EQ33757964-A7CCDF08-49B7-42DF-A3AC-C0DB6E663F35Q33815422-1F51ACA7-7CC6-4D8A-9793-F49C223E6504Q33840268-A963C88F-E53F-439F-93E8-03029465CF49Q33862289-F679A037-B60E-4093-8487-2515FB2AA880
P2860
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The human antimicrobial and ch ...... ocyte and monocyte populations
@ast
The human antimicrobial and ch ...... ocyte and monocyte populations
@en
The human antimicrobial and ch ...... ocyte and monocyte populations
@nl
type
label
The human antimicrobial and ch ...... ocyte and monocyte populations
@ast
The human antimicrobial and ch ...... ocyte and monocyte populations
@en
The human antimicrobial and ch ...... ocyte and monocyte populations
@nl
prefLabel
The human antimicrobial and ch ...... ocyte and monocyte populations
@ast
The human antimicrobial and ch ...... ocyte and monocyte populations
@en
The human antimicrobial and ch ...... ocyte and monocyte populations
@nl
P2093
P3181
P1433
P1476
The human antimicrobial and ch ...... ocyte and monocyte populations
@en
P2093
B Agerberth
G H Gudmundsson
H Jörnvall
R Kiessling
P304
P3181
P407
P577
2000-11-01T00:00:00Z